Incyte's revenues continues to grow, with full-year 2024 revenues reaching $4.2 billion, driven by JAKAFI and OPZELURA. Click ...

Adolescents with alopecia areata achieve hair regrowth with 80% or more of scalp coverage while taking the Janus kinase inhibitor baricitinib, a phase 3 study finds.

With the official confirmation that Cadillac F1 has earned approval to join the Formula 1 2026 grid comes new waves of ...

Mark Allen has asked fans to recommend a warm European country for a much-needed holiday after a “disappointing” defence of ...

Kryen Wilson has admitted he feels more confident than ever after beating defending champion Mark Allen at the Players ...

US biotech Incyte (Nasdaq: INCY) has reported positive results from two Phase III trials of povorcitinib, an oral JAK1 inhibitor. The company said the trials, which tested the drug as an option for ...

A subset of patients treated with delgocitinib cream 20 mg/g for moderate to severe chronic eczema achieved a “super-response,” by week 16, according to a presenter at the American Academy of ...

The round of eight Stage in the Player Championship competition will feature the match between Neil Robertson vs Stuart ...

A first-of-a-kind therapy that inhibits a population of T cells proved active and safe in a phase 3 trial for moderate to severe atopic dermatitis, introducing a novel mechanism to treat ...

The Shippensburg University men’s indoor track & field team secured 10 All-Atlantic Region selections for the 2025 season, as ...

Phison has unveiled a new solution to reduce the running cost of a 1 trillion parameter AI model from $3 million of raw GPU ...

Phison has partnered with Maingear to create the world's first laptop built for AI, which is powered by Phison's aiDAPTIV+ ...